JKO DHA US1318: Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP) for the Primary Care Manager
The DHA HIV PrEP Provider Training is a guide for providers to learn more about the use of HIV PrEP in the MHS to ensure universal access to PrEP at the primary care level. This training includes information about types of FDA-approved medications, patient eligibility, clinic requirements, and best practices for counseling patients. It is intended for all healthcare providers involved in HIV PrEP program at the MTF and Network.
Target Audience
This activity provides continuing education for physicians, nurses, physician associates/physician assistants, pharmacists, and pharmacy technicians. A certificate of attendance is available for other attendees.
Learning Objectives
- Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations.
- Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition.
- Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use.
- Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies.
- Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources.
- Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health
DHA Specialty Care Section - Medicine Clinical Service Line. Authors have no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
LTC Scott Harris Robinson, M.D. Author has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
CAPT Robert Carpenter, M.D. Author has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Francis Obuseh, Ph.D. Author has no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Disclosure: DHA J-7 staff, planners, authors, faculty, and content reviewers for this educational activity have no relevant financial or non-financial relationship(s) relating to the course content or with ineligible companies to disclose.
Available Credit
- 1.00 AAPA
DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 hours of AAPA Category 1 CME credits. Approval is valid until Sunday, March 14, 2027 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
- 1.00 ACCME Non-Physician CME Credit
DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this activity.
- 1.00 ACPE-Pharm
UAN: JA4008136-0000-26-026-H01-P
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 ACPE-Tech
UAN: JA4008136-0000-26-026-H01-T
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge-based activity will provide a maximum of 1.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.00 AMA PRA Category 1 Credit™
DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA J-7 CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
DHA J-7 CEPO is accredited by the Joint Accreditation/Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Course for a maximum of 1.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance
- 1.00 IPCE
In support of improving patient care, DHA J-7 CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Mar 14, 2027.
Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.
Accommodations: Please contact the course instructor to inquire about accommodations. For additional accommodation requests and/or technical support, email [email protected].

Facebook
Twitter
LinkedIn
Forward
Facebook
X
LinkedIn
Forward